These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 13536997)
41. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide. POTTER M; LAW LW J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561 [No Abstract] [Full Text] [Related]
42. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine. SARTORELLI AC; LEPAGE GA Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368 [No Abstract] [Full Text] [Related]
43. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine. HENDERSON JF; JUNGA IG Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260 [No Abstract] [Full Text] [Related]
44. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma]. YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049 [No Abstract] [Full Text] [Related]
45. The development and biochemical characterization of resistance to azaserine in a TA 3 ascites carcinoma. SARTORELLI AC; LePAGE GA Cancer Res; 1958 May; 18(4):457-63. PubMed ID: 13536997 [No Abstract] [Full Text] [Related]